Sourav RoyChoudhury

ORCID: 0000-0001-7914-2842 · 6 papers in corpus · active 2020-2025

Study types

  • article 5
  • other 1

Condition tags

  • adenomyosis 5
  • infertility 4
  • endometriosis 2
  • dysmenorrhea 1
  • mesh:D004715 1
  • mesh:D004412 1
other 2025
Comparative analysis of low-dose letrozole versus GnRH agonist on implantation markers and IVF outcomes in symptomatic adenomyosis: a randomized trial
Scientific reports ·doi:10.1038/s41598-025-32974-z

UNLABELLED: Symptomatic adenomyosis is a known impediment to successful implantation and pregnancy in in vitro fertilization; yet optimal pre-treatment strategic approach remains uncertain. This randomized controlled trial compared the effe…

article 2025
Impact of Localization of Diffuse Adenomyosis on Frozen Embryo Transfer Outcomes and Perinatal Outcomes: A Prospective Cohort Study of 585 Patients
Gynecologic and obstetric investigation ·doi:10.1159/000546437

OBJECTIVE: The objective of this study was to investigate the impact of localization of diffuse adenomyosis on reproductive outcomes after frozen embryo transfer (FET). DESIGN: This prospective cohort study was conducted between January 201…

article 2023
Low-dose letrozole – an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.03.010
article 2023
P-358 Impact of localization of diffuse adenomyosis on reproductive outcomes and pregnancy complications: A prospective cohort study of 585 patients after frozen embryo replacement cycle
·doi:10.1093/humrep/dead093.716

Abstract Study question Does localization of diffuse adenomyosis impact reproductive outcomes after the frozen embryo transfer (FET)? Summary answer Diffuse adenomyotic lesions involving the junctional zone (JZ) have a greater negative impa…

article 2022
P-324 Effectiveness of letrozole in symptomatic women with adenomyosis undergoing IVF: An overview of clinical features, sonographic characteristics, and reproductive outcome
·doi:10.1093/humrep/deac107.308

Abstract Study question Is letrozole pre-treatment a cost-effective option in improving symptoms, sonographic features, and reproductive outcomes in women with adenomyosis, undergoing IVF treatment? Summary answer Only two months of low dos…

article 2020
Pregnancy and Live Birth Rates Are Comparable in Young Infertile Women Presenting with Severe Endometriosis and Tubal Infertility
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00158-x